Clinical Trials
29 trialsNCT07001709 2025-06-03
ENABLE
Deventer Ziekenhuis
Phase 4 Recruiting
NCT06897917 2025-03-27
Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain
Henan Cancer Hospital
Phase 4 Not yet recruiting
NCT05216328 2024-11-22
OMAMA
Amsterdam UMC, location VUmc
Phase 4 Recruiting
NCT06498037 2024-07-12
FERRARI
Erasmus Medical Center
Phase 4 Recruiting
NCT06316908 2024-03-19
Permanent Celiac Plexus Block: Comparison of Pain Score in Unilateral and Bilateral Posterior Percutaneous Approach
Sindh Institute of Urology and Transplantation
Phase 4 Completed
NCT05910190 2023-07-10
Buprenorphine for Cancer Pain
Fox Chase Cancer Center
Phase 4 Unknown
NCT04779567 2021-08-13
Usefulness of Acetaminophen Associated With Strong Opioids for Acute Pain in Cancer Patients
Pontificia Universidad Catolica de Chile
Phase 4 Completed
NCT04801082 2021-03-22
Endoscopic Ultrasound Guided Coeliac Plexus Neurolysis for Cancer Pain
The University of Hong Kong
Phase 4 Unknown
NCT04809935 2021-03-22
EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy
The University of Hong Kong
Phase 4 Unknown
NCT03639415 2021-03-08
Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain
Fujian Cancer Hospital
Phase 4 Withdrawn
NCT03176121 2020-03-18
STOP Pain
Taiwan Mundipharma Pharmaceuticals Ltd.
Phase 4 Completed
NCT03176199 2020-03-18
A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain
Taiwan Mundipharma Pharmaceuticals Ltd.
Phase 4 Completed
NCT00140894 2019-09-20
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)
Merck Sharp & Dohme LLC
Phase 4 Terminated
NCT02660229 2018-11-19
SWITCH
Mundipharma Korea Ltd
Phase 4 Completed
NCT01313780 2017-12-22
TOP
Mundipharma Korea Ltd
Phase 4 Completed
NCT01719757 2016-08-19
PROBE
Mundipharma Korea Ltd
Phase 4 Completed
NCT01809106 2015-12-24
CERP
Mario Negri Institute for Pharmacological Research
Phase 4 Completed
NCT02335398 2015-01-09
Development and Evaluation of a Methadone Protocol for Severe Chronic Pain Management
Mahidol University
Phase 4 Completed
NCT00771199 2014-09-17
An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain
Janssen-Cilag Ltd.
Phase 4 Completed
NCT01060124 2014-04-29
An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Cancer Participants With Inadequately Controlled Pain by Non-Narcotic Analgesics
Janssen Korea, Ltd., Korea
Phase 4 Completed
NCT00916890 2014-01-09
Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase 4 Suspended
NCT00766831 2013-10-23
An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain
Janssen Korea, Ltd., Korea
Phase 4 Completed
NCT01621100 2013-09-06
Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients
Janssen Korea, Ltd., Korea
Phase 4 Completed
NCT00842829 2012-10-01
Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 4 Terminated
NCT01043068 2012-04-27
The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients: A Pilot Study
National Cancer Center, Korea
Phase 4 Completed
NCT00576017 2011-05-19
A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs).
Janssen-Cilag, S.A.
Phase 4 Completed
NCT00236327 2011-05-17
Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain
Janssen Cilag S.A.S.
Phase 4 Terminated
NCT01313247 2011-03-11
Paracetamol for Cancer Pain
Haraldsplass Deaconess Hospital
Phase 4 Unknown
NCT00576173 2010-04-28
An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients
Johnson & Johnson Taiwan Ltd
Phase 4 Completed